Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1985 Nov;20(5):459–462. doi: 10.1111/j.1365-2125.1985.tb05097.x

Bronchial beta-adrenoceptor blockade following eyedrops of timolol and its isomer L-714,465 in normal subjects.

R Richards, A E Tattersfield
PMCID: PMC1400720  PMID: 2866789

Abstract

The R-enantiomer of timolol, L-714,465, is considerably less potent as a beta 1- and beta 2-adrenoceptor antagonist in animals than timolol, whilst only slightly less potent in reducing intraocular pressure. If the same was true in man L-714,465 would have potential benefits over timolol in the treatment of glaucoma. The extent of bronchial beta-adrenoceptor blockade following one eyedrop in each eye of timolol 1% and L-714,465 1% was compared in six normal subjects, by measuring the displacement of the bronchodilator dose-response curve to isoprenaline following each drug compared to the isoprenaline dose-response curve after placebo eyedrops (methyl-cellulose). There was no significant difference between the dose-response curves to L-714,465 and placebo, but a significant displacement of the dose-response curve following timolol. The geometric mean dose ratio following timolol (21) differed significantly from that following L-714,465 (1.6). Heart rate at the end of the isoprenaline dose-response study was lower after timolol, despite the fact that subjects had received higher doses of isoprenaline. The trend was in the same direction after L-714,465 when compared with placebo though less marked. L-714,465 clearly causes less beta-adrenoceptor blockade than timolol when given as 1% eyedrops. The effects of L-714,465 1% on the airways and heart rate did not differ significantly from placebo in these six subjects but the pattern of response would be most consistent with L-714,465 having some beta-adrenoceptor blocking activity though considerably less than timolol.

Full text

PDF
459

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Else O. F., Sorenson H., Edwards I. R. Plasma timolol levels after oral and intravenous administration. Eur J Clin Pharmacol. 1978 Dec 18;14(6):431–434. doi: 10.1007/BF00716385. [DOI] [PubMed] [Google Scholar]
  2. Fraunfelder F. T., Barker A. F. Respiratory effects of timolol. N Engl J Med. 1984 Nov 29;311(22):1441–1441. doi: 10.1056/nejm198411293112213. [DOI] [PubMed] [Google Scholar]
  3. Gribbin H. R., Baldwin C. J., Tattersfield A. E. Quantitative assessment of bronchial beta-adrenoceptor blockade in man. Br J Clin Pharmacol. 1979 Jun;7(6):551–556. doi: 10.1111/j.1365-2125.1979.tb04641.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gribbin H. R., Mackay A. D., Baldwin C. J., Tattersfield A. E. Bronchial and cardiac beta-adrenoceptor blockade--a comparison of atenolol, acebutolol and labetalol. Br J Clin Pharmacol. 1981 Jul;12(1):61–65. doi: 10.1111/j.1365-2125.1981.tb01855.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Jones F. L., Ekberg N. L. Exacerbation of obstructive airway disease by timolol. JAMA. 1980 Dec 19;244(24):2730–2730. [PubMed] [Google Scholar]
  6. Kermode J. C., Edmonds C. J. Pathways of transepithelial potassium movement in the epithelium of distal colon in man. Clin Sci (Lond) 1980 Jul;59(1):29–39. doi: 10.1042/cs0590029. [DOI] [PubMed] [Google Scholar]
  7. Ostergaard Laursen S., Bjerrum P. Timolol eyedrop-induced severe bronchospasm. Acta Med Scand. 1982;211(6):505–506. doi: 10.1111/j.0954-6820.1982.tb01990.x. [DOI] [PubMed] [Google Scholar]
  8. Schoene R. B., Abuan T., Ward R. L., Beasley C. H. Effects of topical betaxolol, timolol, and placebo on pulmonary function in asthmatic bronchitis. Am J Ophthalmol. 1984 Jan;97(1):86–92. doi: 10.1016/0002-9394(84)90450-1. [DOI] [PubMed] [Google Scholar]
  9. Schoene R. B., Martin T. R., Charan N. B., French C. L. Timolol-induced bronchospasm in asthmatic bronchitis. JAMA. 1981 Apr 10;245(14):1460–1461. [PubMed] [Google Scholar]
  10. Tattersfield A. E., Cragg D. J., Bacon R. J. Assessment of beta-adrenoceptor selectivity of a new beta-adrenoceptor antagonist, bisoprolol, in man. Br J Clin Pharmacol. 1984 Sep;18(3):343–347. doi: 10.1111/j.1365-2125.1984.tb02474.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Wilson T. W., Firor W. B., Johnson G. E., Holmes G. I., Tsianco M. C., Huber P. B., Davies R. O. Timolol and propranolol: bioavailability, plasma concentrations, and beta blockade. Clin Pharmacol Ther. 1982 Dec;32(6):676–685. doi: 10.1038/clpt.1982.223. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES